FDA Requires Label Changes to Better Protect Children From Pain and Cough Medicines
By Zachary Brennan -
Published 20 April 2017
The US Food and Drug Administration (FDA) on Thursday announced label changes to two opioids, codeine and tramadol (found in various prescription pain and cough medicines and some over-the-counter cough medicines), to better protect children from serious risks.
Categories: News, US, FDA, Crisis management, Government affairs, Labeling
Tags: codeine, tramadol, label changes